EcoDrugPlus

Ensembl ID : ENSATEG00000025212
Gene Symbol: -
Cross references: -
349 Possible Orthologues:

Ensembl ID : ENSATEG00000019539
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSATEG00000019477
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSATEG00000025349
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSATEG00000018604
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSATEG00000025598
Gene Symbol: -
Cross references: -
154 Possible Orthologues:

Ensembl ID : ENSATEG00000018758
Gene Symbol: -
Cross references: -
259 Possible Orthologues:

Ensembl ID : ENSATEG00000026932
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSATEG00000018380
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSATEG00000027849
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSATEG00000000022
Gene Symbol: -
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSATEG00000000158
Gene Symbol: -
Cross references: -
245 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).